A randomised controlled trial of oxytocin 5 IU versus oxytocin 5 IU and 30 IU infusion for the control of blood loss at elective caesarean section: a pilot study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

ISRCTN

Registry ID

ISRCTN40302163

Enrollment

120

Registered

2007-04-13

Start date

2005-08-29

Completion date

Unknown

Last updated

2015-01-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Study of blood loss associated with different use of syntocinon Pregnancy and Childbirth Study of blood loss associated with different use of syntocinon

Interventions

Women randomly allocated to receive syntocinon 5 IU or syntocinon 5 IU and 30 IU infusion at the time of elective caesarean section using standardised anaesthetic and surgical procedures.

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: Pregnant women choosing to have elective caesarean section at term in a healthy low risk pregnancy.

Exclusion criteria

Exclusion criteria: 1. Women who do not understand English 2. Have a pregnancy complicated by thrombocytopenia 3. Coagulopathy or anti-coagulant therapy 4. Are expecting a multiple birth

Design outcomes

Primary

Measure	Time frame
The primary outcome measure is estimated blood loss at caesarean section.	—

Secondary

Measure	Time frame
1. Change in haemoglobin and haematocrit 2. Need for additional uterotonic agents 3. Incidence of major obstetric haemorrhage 4. Need for blood transfusion, side effects and length of sat in the labour ward	—

Countries

United Kingdom

Outcome results

None listed

Source: ISRCTN (via WHO ICTRP) · Data processed: Apr 2, 2026